An Australian woman who took Ozempic to lose a few pounds before her daughter’s wedding died of a gastrointestinal illness; Now her husband warns that the medication “is not worth it at all.”
Trish Webster, 56, was prescribed Ozempic to help her put on her dream dress for her daughter’s nuptials.
Ozempic is a medication approved by the US Food and Drug Administration for people with type 2 diabetes; It has been widely used as a weight loss drug throughout the world.
The drug works by mimicking a natural hormone, GLP-1, which slows the passage of food through the stomach and intestines, making people feel fuller for longer.
Problems arise if the medication slows down the stomach too much or blocks the intestines.
Intestinal blockage is called “ileus”: The FDA received 18 reports of it in people taking Ozempic in late September.
An Australian woman who took Ozempic to lose a few pounds before her daughter’s wedding died of a gastrointestinal illness; Now her husband warns that the medication “is not worth it at all.” 60 Minutes Australia
For his part, Webster took Ozempic along with the prescription injection Saxenda and lost about 35 pounds in five months, according to local media reports.
While the medications helped Webster lose weight quickly, they allegedly made her sick.
On January 16, just a few months before their daughter’s wedding, Webster’s husband allegedly found her unconscious with brown liquid coming from her mouth.
Trish Webster, 56, was prescribed Ozempic to help her put on her dream dress for her daughter’s nuptials. 60 minutes Australia
“There was a little bit of brown substance coming out of his mouth and I realized he wasn’t breathing and I started doing CPR,” Roy Webster told “60 Minutes Australia” last week.
“It was pouring out and I turned her on her side because she couldn’t breathe.”
Webster died that night and the cause of death was acute gastrointestinal illness.
On January 16, just a few months before their daughter’s wedding, Webster’s husband allegedly found her unconscious with brown liquid coming from her mouth. 60 Minutes Australia “She had a little bit of a brown substance coming out of her mouth, and I realized she wasn’t breathing and I started doing CPR,” Roy Webster said. 60 Minutes Australia
“If she had known that could happen, she wouldn’t have taken it,” the grieving husband insisted. “I never thought you could die from that.”
While Webster’s death has not been officially linked to her use of Ozempic and Saxenda, her husband blames the drugs.
“She shouldn’t have left, you know,” Roy said. “It’s just not worth it, not worth it at all.”
In a statement to “60 Minutes Australia,” Ozempic’s maker, Novo Nordisk, said the ileus was only reported after its “post-marketing environment,” suggesting the drugmaker only became aware of the problem after the medicine was launched.
“She shouldn’t have left, you know,” Roy said. “It’s just not worth it, not worth it at all.” 60 Minutes Australia
Novo Nordisk and Eli Lilly and Company, which makes Mounjaro, are being sued in the United States over claims that their popular weight-loss drugs can cause serious gastrointestinal problems, such as gastroparesis or “stomach paralysis,” which can lead to death.
The law firm Morgan & Morgan told The Post in August that it had received 500 similar inquiries from clients in 45 states, along with claims of injuries allegedly caused by other weight-loss drugs, including Wegovy, Rybelsus and Saxenda.
A Novo Nordisk representative told The Post at the time: “Semaglutide has been extensively examined in robust clinical development programs, large real-world evidence studies and has cumulatively more than 9.5 million patient-years of exposure.” .
The company noted that “gastrointestinal (GI) events are well-known side effects of the GLP-1 class.”
“Patient safety is Lilly’s top priority and we are actively involved in monitoring, evaluating and reporting safety information for all of our medicines,” Lilly told The Post in a statement.
In September, the FDA updated Ozempic’s label to acknowledge complaints of intestinal obstruction in some people who have taken the drug.
The update came after the federal agency received thousands of reports of gastrointestinal problems from Ozempic users.
In September, the FDA updated Ozempic’s label to acknowledge complaints of intestinal obstruction in some people who have taken the drug.60 Minutes Australia
Gastroparesis is just one of many side effects that have been reported, including “Ozempic finger,” “Ozempic burp,” “Ozempic butt,” “Ozempic face,” and strange dreams about celebrities.
Some experts have warned that Ozempic and similar drugs have not been available long enough to study long-term effects (including fears of suicide) and are likely being misused by some as a quick way to lose a few pounds.
Categories: Trending
Source: vtt.edu.vn